INTRODUCTION
============

Pelvic organ prolapse (POP) is a major healthcare problem for elderly women worldwide and has a serious impact on the quality of life. The prevalence rates of POP varied from 41% to 75% \[[@b1-inj-1938014-007]-[@b3-inj-1938014-007]\]. Surgery is the main treatment for advanced POP \[[@b4-inj-1938014-007]\]. Since the introduction of polypropylene mesh for POP in the late 1990s, evidence from randomized trials has shown that transvaginal mesh (TVM) resulted in greater treatment rates than native tissue surgery \[[@b5-inj-1938014-007]\]. Over the years, TVM has ever become a global treatment for POP and has been entered in main surgery in majority pelvic floor surgery centers worldwide \[[@b6-inj-1938014-007]\].

However, the high complications, such as mesh exposure, pelvic pain, and dyspareunia, related to synthetic mesh resulted in warnings from the U.S. Food and Drug Administration in 2008 and 2011 \[[@b7-inj-1938014-007]\]. To decrease mesh-associated complications and improve anatomical outcomes, biological grafts were used as alternatives to synthetic mesh, and grafts derived from cadavers and animal-derived collagen matrices were developed \[[@b8-inj-1938014-007]\]. Culligan et al. \[[@b9-inj-1938014-007]\] compared the surgical outcomes 12 months after laparoscopic sacrocolpopexy (LSC) with porcine dermis and that with polypropylene mesh and found that both had similar outcomes in subjective or objective results. Feldner et al. \[[@b8-inj-1938014-007]\] compared the small intestine submucosa (SIS) graft with traditional colporrhaphy for surgical treatment of anterior vaginal prolapse and found that SIS repair improved point Ba significantly. Liang et al. \[[@b10-inj-1938014-007]\] used complete and nonsplice SIS patches for total pelvic anatomical repair of organ prolapse in 17 patients and found that one patient experienced stage II anterior vaginal wall prolapse after surgery and no organ damage, infection, erosion, or rejection was observed.

Additionally, sacrocolpopexy is the gold standard for the treatment of advanced apical prolapse \[[@b11-inj-1938014-007]\], which is associated with fewer complications. There are few publications about LSC plus colporrhaphy with an SIS graft for advanced POP. Here, we aimed to compare anatomic and functional outcomes after the treatment of advanced POP by LSC plus colporrhaphy with an SIS graft versus TVM.

MATERIALS AND METHODS
=====================

This study was approved by the Ethics Committee and the Institutional Review Board of Obstetrics and Gynecology Hospital. For this retrospective study, data were analyzed from patients who underwent LSC plus colporrhaphy with SIS graft (group A) or TVM (group B) at a tertiary university-affiliated hospital between September 1, 2015 and November 30, 2016. All patients who underwent the above surgical procedures were diagnosed with stage III genital prolapse in at least 2 parts according to the Pelvic Organ Prolapse Quantification (POP-Q) system \[[@b11-inj-1938014-007]\]. Patients with incomplete data, mental disorders, or death during follow-ups were excluded. This study has been reported in accordance with the STROCSS (Strengthening the Reporting of Cohort Studies in Surgery) criteria \[[@b12-inj-1938014-007]\].

The demographic information included age, body mass index, parity, degree of prolapse upon examination, history of either prolapse surgery or hysterectomy and were recorded. Anatomical outcomes were based on POP-Q measurements by 2 experienced surgeons. Functional outcomes were assessed preoperatively and postoperatively by the validated Chinese version of the Pelvic Floor Distress Inventory questionnaire (PFDI-20; range 0--80, with higher scores indicating worse function), including the Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), the Colorectal-Anal Distress Inventory 8 (CRADI-8), the Urinary Distress Inventory 6 (UDI-6), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12; range 0--80, with higher scores indicating better function) \[[@b13-inj-1938014-007],[@b14-inj-1938014-007]\].

Surgery Procedure
-----------------

LSC was performed using polypropylene mesh (4 cm×10 cm; Dynamesh, FEG Textiltechnik, Aachen, Germany), and all surgical procedures were performed as previously described \[[@b15-inj-1938014-007]\]. A midline incision was made along the length of the anterior vaginal wall from the bladder neck to the vaginal apex, and the bladder was dissected from the vaginal mucosa by blunt or sharp dissection until the arcus tendineus bilaterally. The SIS graft was presoaked in saline solution and then cut into a trapezoidal shape based on the vaginal length. Then, the SIS graft was extended from the bladder neck to the vaginal apex and from one vaginal sulcus to the other without tension. Then, 0-prolene was used to fix the graft by suturing the fascia of the arcus tendineus bilaterally. Similarly, posterior repair with the SIS graft was performed. The distal graft was fixed on the margin of the hymen, and the proximal graft was fixed on the vaginal apex. Depending on the site of prolapse, the SIS graft repair could be anterior, posterior, or both. TVM was performed using a synthetic monofilament polypropylene mesh (Gynecare Gynemesh, Ethicon Women's Health and Urology, Somerville, NJ, USA). The surgery was performed as previously described \[[@b16-inj-1938014-007]\]. All surgical procedures were performed by 2 experienced urogynecologists. All patients underwent concurrent hysterectomies. Concurrent midurethral sling procedures were performed based on the outcomes of the urodynamic test and the symptoms of the patients. All procedures were performed under antibiotic coverage.

Surgical outcomes included duration of operation, estimated blood loss, injuries, postoperative hospitalization, fever (temperature\>38°C on 2 occasions), and complications (including mesh exposure, wound infection, and vaginal bleeding). Pelvic examination, including the POP-Q system, was performed at baseline, 6 months after surgery, and annually after surgery. Anatomic success was marked as the achievement of POP stage\<2. Recurrence was defined as the presence of POP stage≥2 at the same site at 12 months after operation. Subjective improvements (including POP symptoms and sexual life) in PFDI-20 and PISQ-12 were assessed in follow-ups.

Statistical Analysis
--------------------

Means and standard deviations were calculated for continuous variables, and frequencies (proportions) were calculated for categorical variables. Chi-square and Student t‑tests were used to calculate P-values where appropriate for changes from preoperation to postoperation. A value of P\<0.05 was considered statistically significant. Statistical analysis was performed using SPSS ver. 16.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

During the study period, 76 patients were enrolled for analysis. In total, 26 patients experienced LSC plus colporrhaphy with the SIS graft, 2 of them were performed concurrent midurethral sling (MUS); 50 patients underwent TVM, 5 of them were given MUS. There were no significant differences in age, body mass index, frequency of stress urinary incontinence, or other characteristics between the 2 groups ([Table 1](#t1-inj-1938014-007){ref-type="table"}). The estimated blood loss during the operation was similar in both groups. However, the length of operation was significantly longer in LSC plus colporrhaphy with the SIS graft than in TVM (P\<0.001). There were no blood transfusions in either group. One patient who underwent TVM experienced bladder injury and was given suturing during the operation and then recovered completely. Nine patients (34.6%) underwent LSC plus colporrhaphy with the SIS graft experienced vaginal infection, which was significantly more than those who underwent TVM (n=7; 14%) (P=0.038). Vaginal infection usually occurred 5 days postoperation and was proven to be infected with *Escherichia coli* or *Enterococcus faecalis* by culturing the vaginal discharge. Moreover, the postoperative hospital stay of group A was significantly longer than that of group B (P\<0.0001). Mesh exposure occurred in both groups, with 8 patients (30.7%) in group A and 5 patients (10%) in group B, which was significantly different (P=0.027). These patients were successfully given mesh excision in outpatients. Patients with mesh exposure in group A were nearly the same as those with vaginal infection. Four women (15.4%) who underwent LSC plus colporrhaphy with the SIS graft complained of pain in the pelvic area, which was relieved gradually after 3 months. The mentioned above patients with complications often had at least 2 complications. Eleven patients with TVM complained of blunt pelvic pain, which gradually diminished after 4 months. The above results are shown in [Table 2](#t2-inj-1938014-007){ref-type="table"}.

Anatomic success (POP stage≤ I) in the LSC plus colporrhaphy with the SIS graft group at 12 months was 92.3% (95% confidence interval \[CI\], 81.3%) and 96% (95% CI, 90.4%--101.6%) in the TVM group. Anatomic outcomes based on POP-Q scores were greatly improved in both groups ([Table 3](#t3-inj-1938014-007){ref-type="table"}). The average POP-Q Aa score was shorter in the TVM group than in the LSC plus colporrhaphy with the SIS graft group at the 12-month follow-up (P=0.05). No differences in Ba, Ap, Bp, or C scores were observed in either group at the follow-ups.

PFDI-20 scores were significantly improved 12 months after operation in both groups (P\<0.001) ([Table 4](#t4-inj-1938014-007){ref-type="table"}). Subjective improvement was reported at the 12-month follow-up by 24 of 26 women (92.3%) in the LSC plus colporrhaphy with the SIS graft group and 46 of 50 women (92%) in the TVM group (P=0.667). When inventories were analyzed separately, POPDI-6 scores and UDI-6 scores were significantly improved in both groups at the 12-month follow-up (P≤0.001). Regarding the CRADI-8 scores, colorectal symptoms were also improved in both groups. In terms of sexual function, 65 patients from both groups were sexually active preoperation, and all of them completed a PISQ-12 questionnaire. There was a statistically significant improvement in these patients after surgery, especially those who underwent LSC combined with colporrhaphy with the SIS graft (P\<0.001) ([Table 4](#t4-inj-1938014-007){ref-type="table"}).

DISCUSSION
==========

It is well known that mesh sacrocolpopexy is the preferred surgical option for apical prolapse \[[@b17-inj-1938014-007]\] and is associated with fewer complications. This present study revealed that LSC plus colporrhaphy with the SIS graft had the same outcomes as TVM in improved anatomic and functional outcomes in patients with advanced POP. The objective outcomes were 95% in patients who underwent LSC plus colporrhaphy with absorbable mesh and 92% in patients who underwent TVM, which were similar to previous studies \[[@b18-inj-1938014-007]\]. The subjective outcomes based on validated questionnaires were 92.3% in the LSC plus colporrhaphy with absorbable mesh group and 92% in the TVM group, demonstrating similar improvements in the quality of life reported in previous studies \[[@b19-inj-1938014-007],[@b20-inj-1938014-007]\].

At more than 1-year follow-up in this study, although the overall success rate was similar, the improvement of sexual function in the LSC plus colporrhaphy with an SIS graft group seemed better than that in the TVM group. Due to cultural reasons, many women in China are reluctant to discuss their sexual experience, which is why our PISQ scores were apparently lower before surgery compared to other studies \[[@b21-inj-1938014-007]\]. In addition, women in the LSC plus colporrhaphy with the SIS graft group achieved better sexual function than that in the TVM group, and this result may be due to longer TVL, absorbable grafts, or both.

The laparoscopic approach should facilitate a more precise anatomic repair and faster recovery. However, the incidence of vaginal infection in the LSC plus colporrhaphy with the SIS graft group was significantly higher than that in the TVM group, and hospital stays were also longer. Vaginal infection usually occurred 5-day postoperation and was proven to be caused by *E. coli* or *E. faecalis* by culturing the vaginal discharge; vaginal infection may result in vaginal apical mesh exposure later. The reasons for this result might be due to the greater degree of skill, extensive specialized training required, longer operative duration, and graft itself \[[@b20-inj-1938014-007]\]. Due to higher complications, we terminated this LSC plus colporrhaphy with the SIS graft for advanced POP; thus, there were only 26 patients enrolled in our study. However, with good anatomical outcomes and substantial improvement of sexual function, LSC plus colporrhaphy with the SIS graft could be considered as an option for treating advanced POP but with extra precaution against vaginal infection, which may increase mesh exposure \[[@b22-inj-1938014-007]\].

The strength of our study included that validated questionnaires were used to preoperatively and postoperatively evaluate every participant. In addition, every woman in our study had follow-ups for at least 1.5 years after surgery, which was longer than most publications. However, there were several limitations to our study. First, this study has the inherent weakness of being a retrospective study. Second, the sample size could be inadequate to detect small differences in the groups, and the power calculation was suboptimal. Further studies with larger samples and longer follow-ups are required to validate the above outcomes.

In conclusion, both surgeries showed excellent results for anatomical outcomes and quality of life after surgeries. The sexual functional improvement in LSC plus colporrhaphy with the SIS graft group was better than that in TVM group. However, the use of SIS graft might increase the exposure of polypropylene mesh exposure. Therefore, we do not recommend LSC plus colporrhaphy with the SIS graft for advanced multiple-compartments prolapse.
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###### 

Characteristics of the patients enrolled

  Characteristic                Group A (n = 26)       Group B (n = 50)       P-value
  ----------------------------- ---------------------- ---------------------- ---------
  Age (yr)                      58 ± 1.6256 (42--70)   59 ± 0.9160 (47--73)   0.480
  Body mass index (kg/m^2^)     23.7 ± 2.4             23.9 ± 2.9             0.220
  Age of menopause (yr)         52.63 ± 1.06           51.2 ± 0.64            0.240
  No. of children               2 (1--5)               2 (1--6)               0.453
  Stress urinary incontinence   9 (34.6)               18 (36.7)              0.870
  Menopause                     20 (76.9)              39 (78.0)              0.545
  Preoperative POP-Q scores                                                   
   Aa                           2.31 ± 1.01            2.38 ± 0.95            0.758
   Ba                           2.65 ± 1.26            2.88 ± 1.15            0.435
   C                            2.31 ± 2.36            2.02 ± 2.68            0.645
   Ap                           --0.23 ± 2.10          --0.24 ± 2.13          0.713
   Bp                           0.77 ± 2.52            0.78 ± 2.71            0.987
   TVL                          7.27 ± 0.60            7.26 ± 0.69            0.954

Values are presented as mean±standard deviation (range), median (range), or number (%).

Group A, laparoscopic sacrocolpopexy plus colporrhaphy with small intestine submucosa graft; group B, transvaginal mesh; POP-Q, pelvic organ prolapse quantification.

###### 

Perioperative outcomes by surgical groups

  Outcome                                 Group A (n = 26)   Group B (n = 50)   P-value
  --------------------------------------- ------------------ ------------------ -----------
  Operative time (min)                    148.8 ± 6.7        94.22 ± 3.46       \< 0.0001
  Blood loss (mL)                         121.2 ± 9.68       102.4 ± 9.47       0.212
  Blood transfusion                       0                  0                  \-
  Injury                                  0                  1                  \-
  Postoperative fever                     10                 25                 0.238
  Vaginal apical infection                9                  7                  0.038
  Mesh exposure                           8                  5                  0.027
  Pain                                    4                  11                 0.54
  Postoperative urinary tract infection   9                  12                 0.237
  Postoperative hospital stays            10.67 ± 0.73       6.9 ± 0.35         \< 0.0001

Values are presented as mean±standard deviation or number.

Group A, laparoscopic sacrocolpopexy plus colporrhaphy with small intestine submucosa graft; group B, transvaginal mesh.

###### 

Anatomic outcomes measured by POP-Q at 2 timepoints after surgery

  Anatomical outcome   Group A (n = 26)   Group B (n = 50)   P-value
  -------------------- ------------------ ------------------ ---------
  6-Month follow-up                                          
   Aa                  --2.77 ± 0.430     --2.78 ± 0.431     0.192
   Ba                  --2.62 ± 0.496     --2.68 ± 0.469     0.423
   C                   --6.54 ± 0.650     --6.48 ± 0.614     0.700
   Ap                  --2.96 ± 0.196     --2.98 ± 0.141     0.639
   Bp                  --2.92 ± 0.271     --2.94 ± 0.239     0.781
   TVL                 7.23 ± 0.429       7.12 ± 0.520       0.355
  12-Month follow-up                                         
   Aa                  --2.69 ± 0.471     --2.76 ± 0.431     0.914
   Ba                  --2.54 ± 0.508     --2.68 ± 0.471     0.050
   C                   --6.50 ± 0.648     --6.44 ± 0.611     0.692
   Ap                  --2.92 ± 0.272     --2.94 ± 0.239     0.781
   Bp                  --2.88 ± 0.326     --2.92 ± 0.274     0.618
   TVL                 7.23 ± 0.429       7.11 ± 0.558       0.380

Values are presented as mean±standard deviation.

Group A, laparoscopic sacrocolpopexy plus colporrhaphy with small intestine submucosa graft; group B, transvaginal mesh; POP-Q, pelvic organ prolapse quantification.

###### 

Functional outcomes at two timepoints after surgery

  Functional outcomes   Group A (n = 26)   Group B (n = 50)   P-value
  --------------------- ------------------ ------------------ ---------
  PFDI-20 score                                               
   Preoperative         48.88 ± 14.89      55.19 ± 17.02      0.114
   12-Month follow-up   17.63 ± 7.10       17.94 ± 7.80       0.866
   P-value              \< 0.001                              
  POPDI-6 score                                               
   Preoperative         23.39 ± 10.20      26.08 ± 11.10      0.308
   12-Month follow-up   7.21 ± 6.19        7.92 ± 6.69        0.656
   P-value              \< 0.001           \< 0.001           
  UDI-6 score                                                 
   Preoperative         18.75 ± 6.99       21.41 ± 8.74       0.183
   12-Month follow-up   6.57 ± 2.68        6.08 ± 2.82        0.470
   P-value              \< 0.001           \< 0.001           
  CRADI-8 score                                               
   Preoperative         6.73 ± 4.20        7.68 ± 4.69        0.386
   12-Month follow-up   3.85 ± 2.04        3.93 ± 2.17        0.859
   P-value              0.003              \< 0.001           
  PISQ-12 score                                               
   Preoperative         10.54 ± 3.23       11.02 ± 3.67       0.574
   12-Month follow-up   16.23 ± 3.79       14.14 ± 3.85       0.027
   P-value              \< 0.001           0.001              

Values are presented as mean±standard deviation.

Group A, laparoscopic sacrocolpopexy plus colporrhaphy with an small intestine submucosa graft; group B, transvaginal mesh; PDFI-20, Pelvic Floor Distress Inventory-20; POPDI, Pelvic Organ Prolapse Distress Inventory; UDI, Urinary Distress Inventory; CARDI, Colorectal-Anal Distress Inventory; PISQ, Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire.
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